Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Challenges in assessing solid tumor responses to immunotherapy.

Chai LF, Prince E, Pillarisetty VG, Katz SC.

Cancer Gene Ther. 2019 Dec 11. doi: 10.1038/s41417-019-0155-1. [Epub ahead of print] Review.

PMID:
31822814
2.

HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases.

Katz SC, Hardaway J, Prince E, Guha P, Cunetta M, Moody A, Wang LJ, Armenio V, Espat NJ, Junghans RP.

Cancer Gene Ther. 2019 Jun 3. doi: 10.1038/s41417-019-0104-z. [Epub ahead of print]

PMID:
31155611
3.

Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54.

Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB.

Vaccines (Basel). 2019 Jan 31;7(1). pii: E15. doi: 10.3390/vaccines7010015.

4.

STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.

Guha P, Gardell J, Darpolor J, Cunetta M, Lima M, Miller G, Espat NJ, Junghans RP, Katz SC.

Oncogene. 2019 Jan;38(4):533-548. doi: 10.1038/s41388-018-0449-z. Epub 2018 Aug 29.

PMID:
30158673
5.

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.

Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB.

Vaccines (Basel). 2018 Aug 10;6(3). pii: E54. doi: 10.3390/vaccines6030054. Review. Erratum in: Vaccines (Basel). 2019 Jan 31;7(1):.

6.

Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells.

Sengupta S, Katz SC, Sengupta S, Sampath P.

Cancer Lett. 2018 Oct 1;433:131-139. doi: 10.1016/j.canlet.2018.06.035. Epub 2018 Jun 27.

PMID:
29959057
7.

Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy.

Hardaway JC, Prince E, Arepally A, Katz SC.

J Vasc Interv Radiol. 2018 Jul;29(7):1017-1021.e1. doi: 10.1016/j.jvir.2018.03.001. No abstract available.

PMID:
29935783
8.

Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.

Mukkamalla SKR, Naseri HM, Kim BM, Katz SC, Armenio VA.

J Natl Compr Canc Netw. 2018 Apr;16(4):370-376. doi: 10.6004/jnccn.2017.7056.

PMID:
29632056
9.

Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer.

Ahmad A, Reha J, Saied A, Espat NJ, Somasundar P, Katz SC.

Hepatobiliary Surg Nutr. 2017 Jun;6(3):154-161. doi: 10.21037/hbsn.2016.08.08.

10.

Frontline Science: Functionally impaired geriatric CAR-T cells rescued by increased α5β1 integrin expression.

Guha P, Cunetta M, Somasundar P, Espat NJ, Junghans RP, Katz SC.

J Leukoc Biol. 2017 Aug;102(2):201-208. doi: 10.1189/jlb.5HI0716-322RR. Epub 2017 May 25.

11.

Regional immunotherapy for liver and peritoneal metastases.

Reha J, Katz SC.

J Surg Oncol. 2017 Jul;116(1):46-54. doi: 10.1002/jso.24641. Epub 2017 May 22. Review.

PMID:
28543176
12.

Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.

Cavnar MJ, Turcotte S, Katz SC, Kuk D, Gönen M, Shia J, Allen PJ, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, DeMatteo RP.

Ann Surg Oncol. 2017 Jul;24(7):1835-1842. doi: 10.1245/s10434-017-5812-8. Epub 2017 Feb 17.

13.

Immunosuppression in liver tumors: opening the portal to effective immunotherapy.

Guha P, Reha J, Katz SC.

Cancer Gene Ther. 2017 Mar;24(3):114-120. doi: 10.1038/cgt.2016.54. Epub 2016 Dec 2. Review.

PMID:
27910858
14.

Combinatorial immunotherapy for melanoma.

George DD, Armenio VA, Katz SC.

Cancer Gene Ther. 2017 Mar;24(3):141-147. doi: 10.1038/cgt.2016.56. Epub 2016 Nov 11. Review.

PMID:
27834353
15.

Predictors of surgical non-referral for colorectal liver metastases.

Ahmad A, Reha J, Somasundar P, Espat NJ, Katz SC.

J Surg Res. 2016 Sep;205(1):198-203. doi: 10.1016/j.jss.2016.06.037. Epub 2016 Jun 21.

PMID:
27621019
16.

Mincle Signaling Promotes Con A Hepatitis.

Greco SH, Torres-Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, Ochi A, Gutierrez J, Salyana MA, Mani VR, Nagaraj SV, Deutsch M, Seifert L, Daley D, Barilla R, Hundeyin M, Nikifrov Y, Tejada K, Gelb BE, Katz SC, Miller G.

J Immunol. 2016 Oct 1;197(7):2816-27. doi: 10.4049/jimmunol.1600598. Epub 2016 Aug 24.

17.

Dermatofibrosarcoma Protuberans.

Reha J, Katz SC.

Surg Clin North Am. 2016 Oct;96(5):1031-46. doi: 10.1016/j.suc.2016.05.006. Review.

PMID:
27542641
18.

Tailoring Surgical Therapy for Extremity Soft Tissue Sarcoma.

Katz SC.

Ann Surg Oncol. 2017 Jan;24(1):13-14. doi: 10.1245/s10434-016-5468-9. Epub 2016 Aug 1. No abstract available.

PMID:
27480357
19.

The impact of age on nodal metastases and survival in gastric cancer.

Ahmad A, Khan H, Cholankeril G, Katz SC, Somasundar P.

J Surg Res. 2016 May 15;202(2):428-35. doi: 10.1016/j.jss.2016.02.043. Epub 2016 Mar 16.

PMID:
27229119
20.

Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.

Thorn M, Guha P, Cunetta M, Espat NJ, Miller G, Junghans RP, Katz SC.

Cancer Gene Ther. 2016 Jun;23(6):188-98. doi: 10.1038/cgt.2016.19. Epub 2016 May 20.

PMID:
27199222
21.

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery.

Katz SC, Point GR, Cunetta M, Thorn M, Guha P, Espat NJ, Boutros C, Hanna N, Junghans RP.

Cancer Gene Ther. 2016 May;23(5):142-8. doi: 10.1038/cgt.2016.14. Epub 2016 Apr 15.

22.

Disparities in Health Insurance Coverage and Health Status Among Farmworkers, Sonoma County, California, 2013-2014.

Moore KL, Mercado J, Hill J, Katz SC.

Prev Chronic Dis. 2016 Mar 31;13:E45. doi: 10.5888/pcd13.150519.

23.

Gastrointestinal stromal tumour metastatic to the epididymis.

Ahmad A, Libbey NP, Somasundar P, Katz SC.

BMJ Case Rep. 2015 Sep 23;2015. pii: bcr2015211555. doi: 10.1136/bcr-2015-211555.

24.

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.

Katz SC, Burga RA, McCormack E, Wang LJ, Mooring W, Point GR, Khare PD, Thorn M, Ma Q, Stainken BF, Assanah EO, Davies R, Espat NJ, Junghans RP.

Clin Cancer Res. 2015 Jul 15;21(14):3149-59. doi: 10.1158/1078-0432.CCR-14-1421. Epub 2015 Apr 7.

25.

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.

Burga RA, Thorn M, Point GR, Guha P, Nguyen CT, Licata LA, DeMatteo RP, Ayala A, Joseph Espat N, Junghans RP, Katz SC.

Cancer Immunol Immunother. 2015 Jul;64(7):817-29. doi: 10.1007/s00262-015-1692-6. Epub 2015 Apr 8.

26.

Chemotherapy does not adversely impact outcome following post-incisional hernia repair with biomaterial mesh.

Saied A, David J, LaBarbera K, Katz SC, Somasundar P.

J Surg Oncol. 2015 May;111(6):725-8. doi: 10.1002/jso.23869. Epub 2015 Jan 8.

27.

Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases.

Saied A, Licata L, Burga RA, Thorn M, McCormack E, Stainken BF, Assanah EO, Khare PD, Davies R, Espat NJ, Junghans RP, Katz SC.

Cancer Gene Ther. 2014 Nov;21(11):457-62. doi: 10.1038/cgt.2014.50. Epub 2014 Oct 3.

28.

Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.

Thorn M, Point GR, Burga RA, Nguyen CT, Joseph Espat N, Katz SC.

J Leukoc Biol. 2014 Nov;96(5):883-94. doi: 10.1189/jlb.3A0114-012RR. Epub 2014 Aug 1.

29.

The prognostic value of liver tumor T cell infiltrates.

Khan H, Pillarisetty VG, Katz SC.

J Surg Res. 2014 Sep;191(1):189-95. doi: 10.1016/j.jss.2014.06.001. Epub 2014 Jun 7. Review.

30.

Hepatic PEComa: a potential pitfall in the evaluation of hepatic neoplasms.

Khan HM, Katz SC, Libbey NP, Somasundar PS.

BMJ Case Rep. 2014 Jun 6;2014. pii: bcr2014204122. doi: 10.1136/bcr-2014-204122.

31.

Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.

Turcotte S, Katz SC, Shia J, Jarnagin WR, Kingham TP, Allen PJ, Fong Y, D'Angelica MI, DeMatteo RP.

Cancer Immunol Res. 2014 Jun;2(6):530-7. doi: 10.1158/2326-6066.CIR-13-0180. Epub 2014 Feb 20.

32.

Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.

Saied A, Katz SC, Espat NJ.

Hepatobiliary Surg Nutr. 2013 Apr;2(2):97-107. doi: 10.3978/j.issn.2304-3881.2012.12.07. Review.

33.

Age-related trends in utilization of the internet and electronic communication devices for coordination of cancer care in elderly patients.

Saied A, Sherry SJ, Castricone DJ, Perry KM, Katz SC, Somasundar P.

J Geriatr Oncol. 2014 Apr;5(2):185-9. doi: 10.1016/j.jgo.2013.11.001. Epub 2013 Dec 7.

PMID:
24495698
34.

Immunotherapy for solid tumors--a review for surgeons.

Saied A, Pillarisetty VG, Katz SC.

J Surg Res. 2014 Apr;187(2):525-35. doi: 10.1016/j.jss.2013.12.018. Epub 2013 Dec 25. Review.

35.

Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.

Licata LA, Nguyen CT, Burga RA, Falanga V, Espat NJ, Ayala A, Thorn M, Junghans RP, Katz SC.

J Leukoc Biol. 2013 Oct;94(4):813-23. doi: 10.1189/jlb.0313137. Epub 2013 Jul 24.

36.

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor.

Katz SC, Burga RA, Naheed S, Licata LA, Thorn M, Osgood D, Nguyen CT, Espat NJ, Fletcher JA, Junghans RP.

J Transl Med. 2013 Feb 21;11:46. doi: 10.1186/1479-5876-11-46.

37.

Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.

Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, DeMatteo RP.

Ann Surg Oncol. 2013 Mar;20(3):946-55. doi: 10.1245/s10434-012-2668-9. Epub 2012 Sep 26.

38.

Feasibility of purely laparoscopic resection of locally advanced rectal cancer in obese patients.

Oyasiji T, Baldwin K, Katz SC, Espat NJ, Somasundar P.

World J Surg Oncol. 2012 Jul 16;10:147. doi: 10.1186/1477-7819-10-147.

39.

Bipolar radiofrequency ablation of liver tumors: technical experience and interval follow-up in 22 patients with 33 ablations.

Baldwin K, Katz SC, Rubin A, Somasundar P.

J Surg Oncol. 2012 Dec;106(7):905-10. doi: 10.1002/jso.23147. Epub 2012 May 4.

PMID:
22566386
40.

The effects of sorafenib on liver regeneration in a model of partial hepatectomy.

Kurniali PC, O'Gara K, Wang X, Wang LJ, Somasundar P, Falanga V, Espat NJ, Katz SC.

J Surg Res. 2012 Nov;178(1):242-7. doi: 10.1016/j.jss.2012.01.033. Epub 2012 Mar 29.

41.

Laparoscopic spleen-preserving distal pancreatectomy in elderly subjects: splenic vessel sacrifice may be associated with a higher rate of splenic infarction.

Baldwin KM, Katz SC, Espat NJ, Somasundar P.

HPB (Oxford). 2011 Sep;13(9):621-5. doi: 10.1111/j.1477-2574.2011.00341.x.

42.

Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Katz SC, Ryan K, Ahmed N, Plitas G, Chaudhry UI, Kingham TP, Naheed S, Nguyen C, Somasundar P, Espat NJ, Junghans RP, Dematteo RP.

J Immunol. 2011 Aug 1;187(3):1150-6. doi: 10.4049/jimmunol.1004077. Epub 2011 Jun 22.

43.

Soft tissue sarcoma diagnosed subsequent to lymphoma is associated with prior radiotherapy and decreased survival.

Katz SC, Baldwin K, Karakousis G, Moraco N, Buglino A, Singer S, Brennan MF.

Cancer. 2011 Oct 15;117(20):4756-63. doi: 10.1002/cncr.26105. Epub 2011 Apr 4.

44.

Abdominal cystic lymphangiomatosis.

Cutler TS, Chaudhry UI, Shukla P, Hiotis SP, Katz SC.

Am Surg. 2010 Dec;76(12):1432-4. No abstract available.

PMID:
21265366
45.

T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.

Katz SC, Donkor C, Glasgow K, Pillarisetty VG, Gönen M, Espat NJ, Klimstra DS, D'Angelica MI, Allen PJ, Jarnagin W, Dematteo RP, Brennan MF, Tang LH.

HPB (Oxford). 2010 Dec;12(10):674-83. doi: 10.1111/j.1477-2574.2010.00231.x.

46.

Management of an incidental liver mass.

Boutros C, Katz SC, Espat NJ.

Surg Clin North Am. 2010 Aug;90(4):699-718. doi: 10.1016/j.suc.2010.04.005. Epub 2010 Jun 9. Review.

PMID:
20637942
47.

Randomized clinical trials in soft tissue sarcoma.

Katz SC, Brennan MF.

Surg Oncol Clin N Am. 2010 Jan;19(1):1-11. doi: 10.1016/j.soc.2009.09.006. Review.

PMID:
19914557
48.

T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.

Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, Gonen M, Jarnagin W, Fong Y, Blumgart L, D'Angelica M, DeMatteo RP.

Ann Surg Oncol. 2009 Sep;16(9):2524-30. doi: 10.1245/s10434-009-0585-3. Epub 2009 Jul 1.

PMID:
19568816
49.

Micromedullary thyroid cancer: how micro is truly micro?

Pillarisetty VG, Katz SC, Ghossein RA, Tuttle RM, Shaha AR.

Ann Surg Oncol. 2009 Oct;16(10):2875-81. doi: 10.1245/s10434-009-0595-1. Epub 2009 Jul 1.

PMID:
19568813
50.

Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.

Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP.

Ann Surg. 2009 Apr;249(4):617-23. doi: 10.1097/SLA.0b013e31819ed22f.

PMID:
19300227

Supplemental Content

Support Center